Case Rep Oncol 2014;7:222–227 DOI: 10.1159/000362161 Published online: March 20, 2014
© 2014 S. Karger AG, Basel 1662‒6575/14/0071‒0222$39.50/0 www.karger.com/cro
This is an Open Access article licensed under the terms of the Creative Commons Attribution-NonCommercial 3.0 Unported license (CC BY-NC) (www.karger.com/OAlicense), applicable to the online version of the article only. Distribution permitted for noncommercial purposes only.
Adrenocortical Carcinoma in an Adult: Eight Months without Recurrence after Resection and Adjuvant Chemotherapy Marcos Duarte Siosaki Leonardo Pelafsky Leonardo Rufino Garcia
Ana Tarsila Fonseca Siosaki
Surgical Oncology Department, Hospital Estadual Bauru, Bauru, Brazil
Key Words Adrenocortical carcinoma · Prognosis · Recurrence · Adjuvant chemotherapy Abstract Adrenocortical carcinoma is a rare, aggressive malignancy that features a correspondingly poor prognosis. The disease accounts for 0.2% of all malignancies and despite multimodal therapies, its prognosis remains poor, with a mean survival of
© 2014 S. Karger AG, Basel 1662‒6575/14/0071‒0222$39.50/0 www.karger.com/cro
This is an Open Access article licensed under the terms of the Creative Commons Attribution-NonCommercial 3.0 Unported license (CC BY-NC) (www.karger.com/OAlicense), applicable to the online version of the article only. Distribution permitted for noncommercial purposes only.
Adrenocortical Carcinoma in an Adult: Eight Months without Recurrence after Resection and Adjuvant Chemotherapy Marcos Duarte Siosaki Leonardo Pelafsky Leonardo Rufino Garcia
Ana Tarsila Fonseca Siosaki
Surgical Oncology Department, Hospital Estadual Bauru, Bauru, Brazil
Key Words Adrenocortical carcinoma · Prognosis · Recurrence · Adjuvant chemotherapy Abstract Adrenocortical carcinoma is a rare, aggressive malignancy that features a correspondingly poor prognosis. The disease accounts for 0.2% of all malignancies and despite multimodal therapies, its prognosis remains poor, with a mean survival of
